《大行報告》摩通上調同程藝龍(00780.HK)目標價至20元 評級「增持」
摩根大通發表研報告,預期同程藝龍(00780.HK)去年第四季收入將按年跌8%,稍遜於公司下跌5%的目標,主要由於去年底內地疫情反覆,令本地旅遊市場需求轉弱,特別是交通票務。
該行預期同程藝龍去年第四季非國際會計準則淨利潤將按年下跌11%,淨利潤率由對上財年同期的16.9%下跌至16.4%,大致符合指引低端;並意味全年淨利潤率達16%,與同業相比表現不俗,並估計毛利率可提升至72.4%,營運成本亦有望下降。
摩通預期,市場將關注農曆新年假期後恢復情況,以及與騰訊(00700.HK)旗下微信錢包的續訂條款,對兩方面都持樂觀態度,維持「增持」評級,目標價由19元升至20元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.